UM
Treatment Rate of Schizophrenia in China: a Meta-Analysis of Epidemiological Studies
Qi,Han1; Zong,Qian Qian2; An,Feng Rong1; Zhang,Ling1; Ungvari,Gabor S.3,4; Sim,Kang5; Park,Seon Cheol6; Xiang,Yu Tao7
2020-09-01
Source PublicationPsychiatric Quarterly
ISSN0033-2720
Volume91Issue:3Pages:863-875
AbstractEffective and prompt medication treatment is essential for schizophrenia patients to alleviate psychotic symptoms and improve prognosis. The treatment rate of schizophrenia usually varies greatly across studies. This is a meta-analysis that examined the overall treatment rate of schizophrenia in China. Both international (PubMed, EMBASE, PsycINFO, Web of Science) and Chinese (CNKI, WanFang and Sinomed) databases were searched. The random effects model was used to analyze the data. Fifteen studies with 1,219,472 patients were included. This meta-analysis found that 73% (95%CI: 66%, 80%) of schizophrenia patients received treatment in any type of medical institutions, while 31.0% (95%CI = 21.0%, 41.0%) received treatment in psychiatric institutions. Studies conducted in middle region of China (76.8% for any type of medical institutions; 42.6% for psychiatric institutions) and those published before 2007 (74.6% for any type of medical institutions; 31.3% for psychiatric institutions) reported significantly higher treatment rates. Studies using combined diagnostic instruments had a higher treatment rate of schizophrenia (72.0%) in any type of medical institutions, while using the Chinese classification of Mental Disorders (47.7%) and including both rural and urban areas (35.7%) had higher treatment rates of schizophrenia in psychiatric institutions. The treatment rate of schizophrenia was relatively high in China, but most treatments were delivered in non-psychiatric medical institutions. Greater efforts should be made to improve the provision of accessible mental health services for schizophrenia patients in this part of the world.
KeywordChina Epidemiological Meta-analysis Schizophrenia Treatment rate
DOI10.1007/s11126-020-09740-7
URLView the original
Language英语
Fulltext Access
Citation statistics
Cited Times [WOS]:1   [WOS Record]     [Related Records in WOS]
Document TypeJournal article
CollectionUniversity of Macau
Affiliation1.The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders,Beijing Anding Hospital & the Advanced Innovation Center for Human Brain Protection,Capital Medical University,Beijing,China
2.School of Nursing,Capital Medical University,Beijing,China
3.The University of Notre Dame Australia,Fremantle,Australia
4.Division of Psychiatry,School of Medicine,University of Western Australia,Perth,Australia
5.West Region,Institute of Mental Health,Buangkok Green, Medical Park,Singapore
6.Department of Psychiatry,Inje Universtiy Haeundae Paik Hospital,Busan,South Korea
7.Center for Cognition and Brain Sciences,University of Macau,Macao SAR,China
Recommended Citation
GB/T 7714
Qi,Han,Zong,Qian Qian,An,Feng Rong,et al. Treatment Rate of Schizophrenia in China: a Meta-Analysis of Epidemiological Studies[J]. Psychiatric Quarterly,2020,91(3):863-875.
APA Qi,Han,Zong,Qian Qian,An,Feng Rong,Zhang,Ling,Ungvari,Gabor S.,Sim,Kang,Park,Seon Cheol,&Xiang,Yu Tao.(2020).Treatment Rate of Schizophrenia in China: a Meta-Analysis of Epidemiological Studies.Psychiatric Quarterly,91(3),863-875.
MLA Qi,Han,et al."Treatment Rate of Schizophrenia in China: a Meta-Analysis of Epidemiological Studies".Psychiatric Quarterly 91.3(2020):863-875.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Qi,Han]'s Articles
[Zong,Qian Qian]'s Articles
[An,Feng Rong]'s Articles
Baidu academic
Similar articles in Baidu academic
[Qi,Han]'s Articles
[Zong,Qian Qian]'s Articles
[An,Feng Rong]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Qi,Han]'s Articles
[Zong,Qian Qian]'s Articles
[An,Feng Rong]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.